{"id":"W2908582202","doi":"10.1055/s-0038-1676983","title":"Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial","year":2019,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Apixaban; Medicine; Warfarin; Concomitant; Aspirin; Internal medicine; Randomized controlled trial; Anesthesia; Rivaroxaban; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002158565,0.0007935801,0.002193704,0.0002999061,0.0001999094,0.0008977528,0.0004753073,0.001327697,0.002607324],"category_scores_gemma":[0.003435208,0.0003627367,0.002086952,0.0004400935,0.0004529808,0.0007429803,0.0004596887,0.001278363,0.0002372775],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002452322,"about_ca_system_score_gemma":0.0003039893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003202189,"about_ca_topic_score_gemma":0.0006008255,"domain_scores_codex":[0.9987538,0.0007803778,0.0001147671,0.0001675072,0.0001038306,0.00007976637],"domain_scores_gemma":[0.9981266,0.0006866747,0.0007602536,0.0001306628,0.00007428191,0.0002216099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9210933,0.001830354,0.04464854,0.00212896,0.008221084,0.0001177039,0.00009289905,0.0005873553,0.001475781,0.0004143967,0.001760286,0.01762937],"study_design_scores_gemma":[0.6974739,0.07279561,0.1983826,0.0008650463,0.01991914,0.0004666366,0.0002353018,0.002427067,0.001321417,0.001585065,0.004418254,0.000109974],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853699,0.01178906,0.000222804,0.0003412038,0.0001674007,0.0002267292,0.0007745228,0.00002087002,0.001087552],"genre_scores_gemma":[0.9941804,0.002364148,0.0004216557,0.0003695524,0.0005244553,0.000424381,0.00114905,0.000005639493,0.0005607391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002607324,"threshold_uncertainty_score":0.01141572,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03675838994211632,"score_gpt":0.300958562619344,"score_spread":0.2642001726772276,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}